eXoZymes
Price & Volume
Stats
See more52W Range | $7.08-$18.40 |
Market Cap | $99M |
Shares Short | 10,666 |
Financials
See moreRevenue (12 Mos) | -$700 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$700 |
Diluted EPS | -$1.09 |
News
See moreYahoo Finance • 2 days ago
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast
Yahoo Finance • 8 months ago
Earnings call transcript: eXoZymes' Q2 2025 focuses on innovation and partnerships
Yahoo Finance • 10 months ago
InvestingPro Fair Value model correctly predicts eXoZymes' 40% price drop
Yahoo Finance • 12 months ago
Bringing clarity and precision to the cell-free space by introducing exozymes
About
CEO | Mr. Michael Heltzen |
Address | 750 Royal Oaks Drive, Monrovia, CA, United States, 91016 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 32 |
